tirzepatide and augmentin cuts risk of diabetes by 94% in adults with prediabetes obesity or overweight, drugmaker says Tirzepatide and Antibiotics: Drug Interaction

Will I experience withdrawal when I stop taking Mounjaro

A triple agonist targeting GLP-1, GIP, and glucagon receptors

Over 27,000 consented participants made this research possible by sharing their experiences with GLP-1 medications through an ongoing research survey

doi: 10.18553/jmcp.2024.23332 30 WallachJDOMalleySSLipskaKJRossJSJefferyMMSavitzST

Well cover some basics (like BMR and activity levels), show how to adjust calories for different goals, and even touch on why TDEE awareness matters for people using GLP-1 weight loss medications

doi: 10.4140/TCP.n.2016.685 38 WaddenTATronieriJSSugimotoDLundMTAuerbachPJensenCet al